期刊文献+

间充质干细胞对干燥综合征模型小鼠治疗效应的研究 被引量:6

Therapeutic effect of mesenchymal stem cells on mice with Sjgren's syndrome
下载PDF
导出
摘要 目的探讨MSCs对晚期干燥综合征(Sjgren's syndrome,SS)模型小鼠的治疗效果及血清中细胞因子浓度的影响。方法 16只雌性NOD/Ltj小鼠随机分为疾病对照组和MSCs治疗组,8只雌性C57BL/6小鼠作为健康对照组。监测各组小鼠饮水量和血糖;MSCs治疗组小鼠26周龄时进行连续2周的尾静脉MSCs注射;测算小鼠唾液流率;计算小鼠的下颌下腺淋巴细胞灶积分;ELISA检测小鼠血清中IL-2、IL-6、HGF、IFN-γ、IL-10、PGE2、TGF-β1、TNF-α的水平。结果从第16周龄开始,NOD小鼠饮水量及血糖水平显著增加;治疗后,M SCs治疗组唾液流率下降幅度明显小于同时期的疾病对照组;MSCs治疗组下颌下腺淋巴细胞灶积分明显小于疾病对照组;3组间多种与SS发病或MSCs免疫抑制功能相关的细胞因子差异有统计学意义。结论 MSCs对晚期干燥综合征模型小鼠有一定的治疗效果,其可能通过改变血清中多种细胞因子浓度达到治疗效应。 Objective To investigate the therapeutic effect of mesenchymal stem cells( MSCs) on mice with Sjgren's syndrome. Methods Sixteen female NOD / Ltj mice were randomized into disease group and MSC treated group,and 8 female C57 BL /6 mice served as normal control group. The mice in MSC treated group received MSCs injection at 26 weeks of age for 2 consecutive weeks. Water intake,blood glucose and salivary flowrate were measured; the lymphocyte infiltration score of submandibular glands was calculated; serum levels of IL-2,IL-6,HGF,IFN-γ,IL-10,PEG2,TGF-β1 and TNF-αwere measured by ELISA. Results Water consumption and blood glucose of NOD mice were increased rapidly after 16 weeks of age. MSCs treatment prevented the decline of salivary flowrate and lymphocytes infiltration in submandibular glands of NOD mice. There were significant differences in serum concentrations of cytokines among 3 groups. Conclusion MSCs treatment is effective for NOD mice with Sjgren's syndrome,which may be associated with the alteration of cytokines levels.
出处 《同济大学学报(医学版)》 CAS 2016年第1期7-11,共5页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金(81273295)
关键词 干燥综合征 间充质干细胞 细胞因子 Sjogren's syndrome mesenchymal stem cells cytokines
  • 相关文献

参考文献1

二级参考文献96

  • 1Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR.Multilineage potential of adult human mesenchymal stem cells.Science 1999; 284: 143-147 [PMID: 10102814 DOI: 10.1126/science.284.5411.143].
  • 2English K. Mechanisms of mesenchymal stromal cellimmunomodulation. Immunol Cell Biol 2013; 91: 19-26 [PMID:23090487 DOI: 10.1038/icb.2012.56].
  • 3Hoogduijn MJ, Crop MJ, Peeters AM, Van Osch GJ, BalkAH, Ijzermans JN, Weimar W, Baan CC. Human heart,spleen, and perirenal fat-derived mesenchymal stem cells haveimmunomodulatory capacities. Stem Cells Dev 2007; 16: 597-604[PMID: 17784833 DOI: 10.1089/scd.2006.0110].
  • 4De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, ZhuM, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, FraserJ, Hedrick MH. Comparison of multi-lineage cells from humanadipose tissue and bone marrow. Cells Tissues Organs 2003; 174:101-109 [PMID: 12835573 DOI: 10.1159/000071150].
  • 5Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatalhuman dental pulp stem cells (DPSCs) in vitro and in vivo. ProcNatl Acad Sci USA 2000; 97: 13625-13630 [PMID: 11087820 DOI:10.1073/pnas.240309797].
  • 6Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD,Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M,Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, VerfaillieCM. Pluripotency of mesenchymal stem cells derived from adultmarrow. Nature 2002; 418: 41-49 [PMID: 12077603 DOI: 10.1038/nature00870].
  • 7Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics,self-renewal, and the osteogenic potential of purified humanmesenchymal stem cells during extensive subcultivation andfollowing cryopreservation. J Cell Biochem 1997; 64: 278-294[PMID: 9027588 DOI: 10.1002/(SICI)1097-4644(199702)64:2<278: : AID-JCB11>3.0.CO; 2-F].
  • 8Prockop DJ. Repair of tissues by adult stem/progenitor cells(MSCs): controversies, myths, and changing paradigms. Mol Ther2009; 17: 939-946 [PMID: 19337235 DOI: 10.1038/mt.2009.62].
  • 9Frenette PS, Pinho S, Lucas D, Scheiermann C. Mesenchymalstem cell: keystone of the hematopoietic stem cell niche and astepping-stone for regenerative medicine. Annu Rev Immunol2013; 31: 285-316 [PMID: 23298209 DOI: 10.1146/annurevimmunol-032712-095919].
  • 10Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, RitterT. Concise review: adult mesenchymal stromal cell therapy forinflammatory diseases: how well are we joining the dots- Stem Cells2013; 31: 2033-2041 [PMID: 23766124 DOI: 10.1002/stem.1452].

共引文献14

同被引文献22

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部